Propranolol and Von Hippel-Lindau Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Propranolol and Von Hippel-Lindau Disease — Stella

Home/Hemangioblastoma of CNS/

View on ClinicalTrials.gov

Recruiting

Back to Hemangioblastoma of CNS trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

Agence Générale des Equipements et Produits de Santé

Enrollment target

~85 participants

Started

January 2023

Primary completion

November 2026

Age range

18 Years and older

Last updated December 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.